Unusual recurrence in advanced ovarian cancer after interval cytoreductive surgery and HIPEC

被引：0
|
作者：
Sonkusare, Shipra [1 ,2 ]
Prasannakumar, Somashekhar Sampige [3 ]
Ahuja, Vijay [1 ]
Kumar, Rohit [3 ]
机构：
[1] Aster Hosp Inc, Gynaecol Oncol, Bangalore, Karnataka, India
[2] All India Inst Med Sci Nagpur, Obstet & Gynaecol, Nagpur, Maharashtra, India
[3] Aster Hosp Inc, Surg Oncol, Bangalore, Karnataka, India
来源：
BMJ CASE REPORTS | 2025年 / 18卷 / 01期
关键词：
Cancer - see Oncology; Obstetrics and gynaecology; Cancer; Oncology; CHEMOTHERAPY; BEVACIZUMAB; DOXORUBICIN; PACLITAXEL; SURVIVAL; TRIAL;
D O I：
10.1136/bcr-2024-262137
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Ovarian cancer is the second most fatal gynaecological malignancy. The relapses after treatment of ovarian cancer usually occur within 2 years after completion of the first-line therapy. Recurrent ovarian cancer commonly presents as peritoneal surface deposits in the abdomen with or without ascites. A delayed relapse presenting as a solitary lesion in the urinary bladder wall is unusual in patients treated for advanced ovarian cancer. We report the successful management of a case of solitary metastasis of ovarian cancer in the urinary bladder wall, which occurred more than 6 years after achieving a complete remission state.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] RECURRENCE OF OVARIAN CANCER AFTER PELVIC AND EXTENDED PERITONECTOMY IN CYTOREDUCTIVE SURGERY
    Ang, J.
    Chia, C.
    Tan, G.
    Teo, M.
    Chew, G. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 608 - 611
  • [22] The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma
    Kennard, J. A.
    Stephens, A. J.
    Manyam, M.
    Fitzsimmons, C. K.
    Kilowski, K. A.
    DeCoff, K. M.
    Ahmad, S.
    Pepe, J. W.
    McKenzie, N. D.
    Kendrick, J. E.
    Holloway, R. W.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 154 - 154
  • [23] Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on “Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer—A Phase 3 Clinical Trial”
    B. Noiret
    N. Bakrin
    C. Eveno
    Annals of Surgical Oncology, 2022, 29 : 3357 - 3358
  • [24] COMPARISON OF QUALITY OF LIFE AFTER SECONDARY CYTOREDUCTIVE SURGERY (SCS) ± HIPEC IN RECURRENT OVARIAN CANCER
    Petrillo, M.
    Costantini, B.
    Cianci, S.
    Ronsini, C.
    Scambia, G.
    Fagotti, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 63 - 63
  • [25] Comparison of quality of life after secondary cytoreductive surgery (SCS) ± HIPEC in recurrent ovarian cancer
    Petrillo, M.
    Costantini, B.
    Cianci, S.
    Ronsini, C.
    Cosentino, F.
    Shallayeva, E.
    Scambia, G.
    Fagotti, A.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 125 - 125
  • [26] Combining HIPEC to Interval Surgery in Ovarian Cancer? One Step Forward with a Second Randomized Study: Comment on "Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer-A Phase 3 Clinical Trial"
    Noiret, B.
    Bakrin, N.
    Eveno, C.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (05) : 3357 - 3358
  • [27] Cytoreductive Surgery with HIPEC as Primary Treatment for Advanced Epithelial Ovarian Carcinoma: Upfront or Interval-ISPSM Collaborative Study
    Somashekhar, S. P.
    Ramya, Y.
    Ashwin, K. R.
    Fernandes, Aaron Marian
    Ahuja, Vijay
    Namachivayam, Arun Kumar
    Kumar, C. Rohit
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2023, 14 (SUPPL 1) : 226 - 232
  • [28] Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
    Ansaloni, Luca
    Agnoletti, Vanni
    Amadori, Andrea
    Catena, Fausto
    Cavaliere, Davide
    Coccolini, Federico
    De Iaco, Pierandrea
    Di Battista, Monica
    Framarini, Massimo
    Gazzotti, Filippo
    Ghermandi, Claudio
    Kopf, Barbara
    Saponara, Maristella
    Tauceri, Francesca
    Vallicelli, Carlo
    Verdecchia, Giorgio Maria
    Pinna, Antonio Daniele
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 778 - 785
  • [29] Cytoreductive surgery (CRS) and HIPEC in recurrent platinum resistant ovarian cancer
    Brown, C. K.
    Williams, S.
    McNutt, L.
    Beilick, S.
    Flynn, R.
    Litvack, D.
    Huss, H.
    Nair, A. R.
    Del Priore, G.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 114 - 114
  • [30] Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
    Tentes, A. A. K.
    Palaskas, T. B.
    Stamou, K.
    Stoforos, C. E.
    Pallas, N.
    Karamveri, C.
    Kyziridis, D.
    Hristakis, C.
    Kyriakopoulos, V
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 48 - 54
12345